Micro-Dystrophin Gene Therapy Reveals Hidden Immune Storm in Treated Boys
A proteomic study of the phase 1/2a delandistrogene moxeparvovec trial shows that high-dose AAV gene therapy triggers a sharp but ...
A proteomic study of the phase 1/2a delandistrogene moxeparvovec trial shows that high-dose AAV gene therapy triggers a sharp but ...
A year-long dual-laboratory study of 51 healthy donors shows that immunoglobulin subclass levels are remarkably stable within individuals yet vary ...
A new analysis of the phase 3 ORIENT-11 trial suggests that the future of lung-cancer immunotherapy may depend not only ...
In recent years, the challenge of diagnosing serious bacterial infections (SBIs) in febrile infants has posed a formidable obstacle for ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine